Sort   by:  
 Page size 
Proteomics: Robust and reproducible large-scale label-free deep quantitative profiling of the MOLM-14 surfaceome using three mass spectrometry platforms over multiple years
Surface proteins are one of the most important and common matrices for clinical chemistry and proteomic analyses. With the rapid developments in mass spectrometry (MS)-based proteomics methods, label-free quantitative proteomics has become an increasingly popular tool for profiling global protein ab...
ORGANISM(S): Homo sapiens (Human) 
2021-12-30 | PXD022721 | Pride
Quantitative proteomics Reproducibility Label-free quantification Mass spectrometry Surfaceome Large-scale 
UnknownCD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531.
Not available
S-EPMC5549451 | biostudies-literature
UnknownMicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia.
Not available
S-EPMC5721230 | biostudies-literature
UnknownGemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531.
Not available
S-EPMC4162498 | biostudies-literature
UnknownCollaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.
Not available
S-EPMC4567700 | biostudies-literature
UnknownIntegrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trials.
Not available
S-EPMC11294346 | biostudies-literature
Sort   by:  
 Page size